AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Cognitive Dysfunction

Showing 21 to 30 of 499 articles

Clear Filters

Automatic Detection of Cognitive Impairment in Patients With White Matter Hyperintensity Using Deep Learning and Radiomics.

American journal of Alzheimer's disease and other dementias
White matter hyperintensity (WMH) is associated with cognitive impairment. In this study, 79 patients with WMH from hospital 1 were randomly divided into a training set (62 patients) and an internal validation set (17 patients). In addition, 29 WMH p...

SERPINA3: A Novel Therapeutic Target for Diabetes-Related Cognitive Impairment Identified Through Integrated Machine Learning and Molecular Docking Analysis.

International journal of molecular sciences
Diabetes-related cognitive impairment (DCI) is a severe complication of type 2 diabetes mellitus (T2DM), with limited understanding of its molecular mechanisms hindering effective therapeutic development. This study identified SERPINA3 as a potential...

Stages prediction of Alzheimer's disease with shallow 2D and 3D CNNs from intelligently selected neuroimaging data.

Scientific reports
Detection of Alzheimer's Disease (AD) is critical for successful diagnosis and treatment, involving the common practice of screening for Mild Cognitive Impairment (MCI). However, the progressive nature of AD makes it challenging to identify its causa...

Neuropsychological tests and machine learning: identifying predictors of MCI and dementia progression.

Aging clinical and experimental research
BACKGROUND: Early prediction of progression in dementia is of major importance for providing patients with adequate clinical care, with considerable impact on the organization of the whole healthcare system.

Develop and validate machine learning models to predict the risk of depressive symptoms in older adults with cognitive impairment.

BMC psychiatry
BACKGROUND: Cognitive impairment and depressive symptoms are prevalent and closely interrelated mental health issues in the elderly. Traditional methods for identifying depressive symptoms in this population often lack effectiveness. Machine learning...

A comprehensive interpretable machine learning framework for mild cognitive impairment and Alzheimer's disease diagnosis.

Scientific reports
An interpretable machine learning (ML) framework is introduced to enhance the diagnosis of Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) by ensuring robustness of the ML models' interpretations. The dataset used comprises volumetric me...

Development and validation of radiomics and deep transfer learning models to assess cognitive impairment in patients with cerebral small vessel disease.

Neuroscience
Cognitive impairment in cerebral small vessel disease (CSVD) progresses subtly but carries significant clinical consequences, necessitating effective diagnostic tools. This study developed and validated predictive models for CSVD-related cognitive im...

Dementia Overdiagnosis in Younger, Higher Educated Individuals Based on MMSE Alone: Analysis Using Deep Learning Technology.

Journal of Korean medical science
BACKGROUND: Dementia is a multifaceted disorder that affects cognitive function, necessitating accurate diagnosis for effective management and treatment. Although the Mini-Mental State Examination (MMSE) is widely used to assess cognitive impairment,...

Deep learning-based classification of dementia using image representation of subcortical signals.

BMC medical informatics and decision making
BACKGROUND: Dementia is a neurological syndrome marked by cognitive decline. Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the common forms of dementia, each with distinct progression patterns. Early and accurate diagnosis of dementi...

Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach.

The international journal of neuropsychopharmacology
BACKGROUND: The global prevalence of dementia is significantly increasing. Early detection and prevention strategies, particularly for mild cognitive impairment (MCI), are crucial but currently hindered by the lack of established biomarkers. Here, we...